Michael Hauptmann

15.5k total citations · 3 hit papers
191 papers, 9.1k citations indexed

About

Michael Hauptmann is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Hauptmann has authored 191 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 56 papers in Cancer Research and 49 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Hauptmann's work include Breast Cancer Treatment Studies (35 papers), Radiation Dose and Imaging (30 papers) and Effects of Radiation Exposure (21 papers). Michael Hauptmann is often cited by papers focused on Breast Cancer Treatment Studies (35 papers), Radiation Dose and Imaging (30 papers) and Effects of Radiation Exposure (21 papers). Michael Hauptmann collaborates with scholars based in Netherlands, United States and Germany. Michael Hauptmann's co-authors include Flora E. van Leeuwen, Marc J. van de Vijver, Sabine C. Linn, Michele M. Doody, Alice J. Sigurdson, Bruce H. Alexander, Berthe M.P. Aleman, Hugo M. Horlings, Jay H. Lubin and Richard B. Hayes and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Hauptmann

182 papers receiving 8.8k citations

Hit Papers

A Functional Genetic Approach Identifies the PI3K Pathway... 2007 2026 2013 2019 2007 2015 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer
    2007 1.2k citations Sabine C. Linn, Michael Hauptmann et al. profile →
  2. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
    2015 324 citations Michael Hauptmann, Flora E. van Leeuwen et al. profile →
  3. Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands
    2018 225 citations Patrycja Gradowska, Flora E. van Leeuwen et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hauptmann Netherlands 50 2.7k 2.5k 2.0k 2.0k 1.9k 191 9.1k
Isabel dos‐Santos‐Silva United Kingdom 47 4.1k 1.5× 989 0.4× 1.4k 0.7× 1.1k 0.6× 2.4k 1.2× 155 9.4k
Kiyóhiko Mabuchi United States 57 2.8k 1.0× 8.3k 3.4× 1.6k 0.8× 1.7k 0.8× 3.4k 1.8× 175 15.4k
Florent de Vathaire France 56 2.5k 0.9× 2.2k 0.9× 938 0.5× 1.3k 0.7× 1.9k 1.0× 279 11.3k
Marilyn Stovall United States 74 3.7k 1.4× 2.8k 1.1× 1.6k 0.8× 2.0k 1.0× 3.5k 1.8× 166 16.9k
Gang Chen China 48 2.4k 0.9× 922 0.4× 1.8k 0.9× 4.3k 2.2× 2.4k 1.3× 576 12.3k
Ruth A. Kleinerman United States 45 1.5k 0.6× 2.2k 0.9× 730 0.4× 882 0.4× 1.6k 0.8× 128 7.5k
Faith G. Davis United States 47 2.5k 0.9× 1.4k 0.6× 1.4k 0.7× 2.1k 1.1× 2.9k 1.5× 147 10.4k
Valerie McCormack France 44 3.6k 1.3× 865 0.4× 1.3k 0.6× 749 0.4× 2.3k 1.2× 132 7.4k
Charles Stiller United Kingdom 63 3.4k 1.3× 800 0.3× 968 0.5× 2.6k 1.3× 2.9k 1.5× 223 13.9k
Peter D. Inskip United States 52 1.5k 0.5× 1.6k 0.6× 866 0.4× 1.2k 0.6× 1.6k 0.8× 138 8.7k

Countries citing papers authored by Michael Hauptmann

Since Specialization
Citations

This map shows the geographic impact of Michael Hauptmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hauptmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hauptmann more than expected).

Fields of papers citing papers by Michael Hauptmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hauptmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hauptmann. The network helps show where Michael Hauptmann may publish in the future.

Co-authorship network of co-authors of Michael Hauptmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hauptmann. A scholar is included among the top collaborators of Michael Hauptmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hauptmann. Michael Hauptmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Veit, Christof, Simone Wesselmann, Stephanie Stock, et al.. (2022). Versorgungsnahe Daten für Versorgungsanalysen – Teil 3 des Manuals. Das Gesundheitswesen. 85(08/09). 718–724. 6 indexed citations
3.
Hauptmann, Michael, et al.. (2022). Contextualising the association of socioeconomic deprivation with hospitalisation rates of myocardial infarction in a rural area in eastern Germany. Rural and Remote Health. 22(2). 6658–6658. 2 indexed citations
4.
Heemskerk-Gerritsen, B.A.M., Ewout W. Steyerberg, Michael Hauptmann, et al.. (2021). Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study. The Breast. 61. 98–107. 5 indexed citations
5.
Jóźwiak, Katarzyna, Gabe S. Sonke, Elsken van der Wall, et al.. (2021). Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients. JNCI Journal of the National Cancer Institute. 113(11). 1506–1514. 5 indexed citations
6.
Boer, Mintsje de, Michael Hauptmann, Nathalie J. Hijmering, et al.. (2020). Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast. Blood. 136(11). 1368–1372. 25 indexed citations
7.
Giardiello, Daniele, Iris Kramer, Maartje J. Hooning, et al.. (2020). Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer. npj Breast Cancer. 6(1). 60–60. 10 indexed citations
8.
Harbeck, Nadia, Ulrike Nitz, Matthias Christgen, et al.. (2020). LBA14 De-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs trastuzumab+ET in early HR+/HER2+ breast cancer (BC): ADAPT-TP survival results. Annals of Oncology. 31. S1146–S1146. 5 indexed citations
9.
Jóźwiak, Katarzyna, Heikki Joensuu, Mark Opdam, et al.. (2020). 193P Adjuvant capecitabine-containing chemotherapy is effective in both BRCA1-like and non-BRCA1-like early-stage TNBC patients. Annals of Oncology. 31. S320–S320. 1 indexed citations
10.
Wójcik, Andrzej, Simon Bouffler, Michael Hauptmann, & Preetha Rajaraman. (2018). Considerations on the use of the terms radiosensitivity and radiosusceptibility. Journal of Radiological Protection. 38(3). N25–N29. 7 indexed citations
11.
Droog, Marjolein, Ekaterina Nevedomskaya, Yongsoo Kim, et al.. (2016). Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas. Cancer Research. 76(13). 3773–3784. 26 indexed citations
12.
Schouten, Philip C., Marieke A. Vollebergh, Mark Opdam, et al.. (2015). High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1 -like Breast Cancer. Molecular Cancer Therapeutics. 15(1). 190–198. 43 indexed citations
13.
Schouten, Philip C., Frederik Marmé, Sebastian Aulmann, et al.. (2014). Breast Cancers with a BRCA1 -like DNA Copy Number Profile Recur Less Often Than Expected after High-Dose Alkylating Chemotherapy. Clinical Cancer Research. 21(4). 763–770. 30 indexed citations
14.
15.
Borst, Gerben R., Masayori Ishikawa, Jasper Nijkamp, et al.. (2010). Radiation Pneumonitis After Hypofractionated Radiotherapy: Evaluation of the LQ(L) Model and Different Dose Parameters. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1596–1603. 55 indexed citations
16.
Kok, Marleen, Wilbert Zwart, Caroline Holm, et al.. (2010). PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer. Breast Cancer Research and Treatment. 125(1). 1–12. 46 indexed citations
17.
Chodick, G., Nural Bekiroğlu, Michael Hauptmann, et al.. (2008). Risk of Cataract after Exposure to Low Doses of Ionizing Radiation: A 20-Year Prospective Cohort Study among US Radiologic Technologists. American Journal of Epidemiology. 168(6). 620–631. 322 indexed citations
18.
Ha, Mina, Kiyóhiko Mabuchi, Alice J. Sigurdson, et al.. (2007). Smoking Cigarettes before First Childbirth and Risk of Breast Cancer. American Journal of Epidemiology. 166(1). 55–61. 44 indexed citations
19.
Sigurdson, Alice J., Deirdre A. Hill, Michael Hauptmann, et al.. (2004). DNA damage in breast cancer plus another primary cancer, early onset breast cancer, thyroid cancer and cancer-free individuals. Cancer Research. 64. 666–666. 1 indexed citations
20.
Hauptmann, Michael, et al.. (1994). La capacidad de la fuerza y su entrenamiento. 8(1). 31–38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel dos‐Santos‐Silva Breakdown of academic impact, for papers by Kiyóhiko Mabuchi Breakdown of academic impact, for papers by Florent de Vathaire Breakdown of academic impact, for papers by Marilyn Stovall Breakdown of academic impact, for papers by Gang Chen Breakdown of academic impact, for papers by Ruth A. Kleinerman Breakdown of academic impact, for papers by Faith G. Davis Breakdown of academic impact, for papers by Valerie McCormack Breakdown of academic impact, for papers by Charles Stiller Breakdown of academic impact, for papers by Peter D. Inskip
Rankless by CCL
2026